National Bank of Canada’s Clearmind Medicine CMND Stock Holding History

National Bank of Canada’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$387	–	2919
2025 Q3	$387	Hold	1	–	–	﹤0.01%	2711
2025 Q2	$334	Hold	1	–	–	﹤0.01%	2794
2025 Q1	$390	Hold	1	–	–	﹤0.01%	2653
2024 Q4	$523	Hold	1	–	–	﹤0.01%	2716
2024 Q3	$462	Buy	+1	New	+$569	﹤0.01%	2485

Other funds holding CMND

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

National Bank of Canada's CMND Position: Q4 2025 in Review

National Bank of Canada sold out of Clearmind Medicine (CMND) in Q4 2025, closing a stake of 1 share — an estimated $387 sold.

National Bank of Canada first reported a position in CMND in Q3 2024 and held it in 5 quarters. The position peaked at $523 in Q4 2024. 3 funds tracked by Wall St. Rank hold CMND as of Q4 2025.

National Bank of Canada reported no remaining Clearmind Medicine position as of Q4 2025 after selling out during the quarter.
National Bank of Canada sold 1 Clearmind Medicine share in Q4 2025, an estimated $387.
National Bank of Canada first reported a position in Clearmind Medicine in Q3 2024 and held it in 5 quarters.
National Bank of Canada's Clearmind Medicine position peaked at $523 in Q4 2024.
3 funds tracked by Wall St. Rank held Clearmind Medicine as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.